Microsimulation modelling to predict the burden of CKD and the cost-effectiveness of timely CKD screening in Belgium: results from the Inside <b/> CKD study
Without changes to current practice, the disease burden of CKD in Belgium is predicted to remain substantial over the next few years. This highlights the need for timely diagnosis of CKD and demonstrates that, in line with guideline recommendations, implementing a CKD screening programme involving UACR and eGFR measurements followed by treatment would be cost-effective.
Authors
- Rucha Vadia (ORCID: https://orcid.org/0000-0003-2533-1669)
- Annelies Vankeirsbilck
- Michel Jadoul (ORCID: https://orcid.org/0000-0001-7369-7812)
- Juan José García Sánchez (ORCID: https://orcid.org/0000-0001-6546-7769)
- Lise Retat (ORCID: https://orcid.org/0000-0002-6689-3599)
- Gert Meeus (ORCID: https://orcid.org/0000-0002-0649-6372)
- Elien Mahieu (ORCID: https://orcid.org/0000-0003-3131-1488)
- Joshua Card-Gowers (ORCID: https://orcid.org/0000-0002-9928-8862)
- E. Vandendriessche
- Gijs Van Pottelbergh (ORCID: https://orcid.org/0000-0002-0844-8673)
- François Jouret
Institutions
- Cliniques Universitaires Saint-Luc (BE)
- AZ Groeninge (BE)
- Flanders Make (Belgium) (BE)
- Centre Hospitalier Universitaire de Liège (BE)
- AstraZeneca (Poland) (PL)
- AstraZeneca (Spain) (ES)
- KU Leuven (BE)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1136/bmjopen-2024-098420
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00